The nonprofit Alliance for Aging Research has released a whitepaper, "Our Best Shot: Expanding Prevention through Vaccination in Older Adults," that provides a comprehensive overview of the factors that drive vaccination underutilization in seniors and offers recommendations on how industry, government, and health care experts can improve patient compliance.
Although influenza, pneumococcal, tetanus, and shingles vaccines are routinely recommended for older adults, are cost-effective, are covered to varying degrees by health insurance, and prevent conditions that have relatively high incidence rates and disease burdens, vaccination rates among older adults are much lower than current targets set by the U.S. government's Healthy People 2020 Initiative.
This magnifies a serious problem that underutilization of vaccines presents to the U.S. healthcare system when viewed through statistics. Each year between five and 10 million Americans acquire pneumonia, 35 million to 50 million are afflicted with influenza, and 1 million get singles. Older Americans are much more likely to get these infections and to suffer from complications and death. The death rate from pneumonia and influenza combined is close to 130 times higher in people ages 85 and older as compared to people ages 45 to 54.
"Vaccinations are available for many of the most common and deadly infectious diseases in older Americans and can save countless lives and health care dollars," says Susan Peschin, MHS, president and CEO of the Alliance. "Unfortunately, vaccination rates in seniors fall far short of target rates recommended by the Centers for Disease Control and Prevention. We think that there is a lot of low-hanging fruit--in promotion of existing preventive health services, access and administration policies, and financial strategies--that would increase utilization and improve public health for older adults. We need to raise the level of importance of immunization among seniors to the level we currently have for children, and then we need to make some basic changes to support it."
The whitepaper, which was authored by Richard Manning, PhD, of Bates White Economic Consulting, LLC, reviews vaccination levels, trends and targets, incidence rates, relevant health insurance coverage policies, and the cost effectiveness literature and other reports that have evaluated vaccine utilization in the older adult population. It then offers analysis of the various barriers that keep older adults from receiving vaccinations, including lack of access to education, financial resources, adequate healthcare and other factors. It also gives recommendations in three specific areas: information, health care and administrative, and financial.
The whitepaper was created with support from GlaxoSmithKline and Merck.
Source: Alliance for Aging Research
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.